Up and Coming
Provided by Flávio Augusto Spegiorin Ramos
Life Sciences and Healthcare
Agrisciences
Administrative and Regulatory Law
Litigation
Consumer Law and Product Liability
Government Relations and Interface with Regulatory Agencies
Constitutional Law
Member of the Consumer Relations Committee at IBRAC (Brazilian Institute of Studies on Competition, Consumer Affairs and International Trade)
Previously served as a member of the Health Law Commission of the Brazilian Bar Association, São Paulo Section
Previously served as a Constitutional Law teaching assistant at the Universidade de São Paulo (USP) – Law School
Flávio Spegiorin is named partner at KVTS, where he leads high stakes matters for national and multinational companies across Life Sciences, Agrisciences, and Litigation. With 15 years of experience in this sector, Flávio has built a reputation for handling complex and sensitive cases that demand deep legal insight, strategic thinking, and precision execution. He is widely recognized for his leadership in regulatory matters, particularly in industries subject to intense oversight such as pharmaceuticals, food, cosmetics, medical devices, agriculture, retail (including e-commerce), and technology. Flávio advises clients on the development of projects that require a comprehensive understanding of Regulatory Law, combining legal rigor with a business-oriented approach to deliver solutions aligned with corporate strategy and compliance demands. Flávio holds a Law degree from UNESP, completed a partnership program in France (Université Jean Moulin Lyon 3) as part of his master’s degree at USP (University of São Paulo Law School), and earned both a Master of Laws and a PhD from USP — Brazil’s most prestigious academic institution. His academic background, combined with his market experience, positions him as a reference in the legal community, consistently mentioned by clients and peers in national and international publications. Flávio stands out for his ability to bridge legal complexity with business pragmatism, offering high-level expertise with strategic clarity — a combination that has made him a trusted advisor and a leading name in the Brazilian legal market. He is recognized and mentioned by clients and peers in international publications such as “Chambers & Partners” (Life Sciences); “Benchmark Litigation”, “IFRL 1000 – Financial and Corporate”; “The Legal 500”; “Análise – Advocacia 500”; “Best Lawyers”; and “Leaders League”.
UNESP
Law Degree
2011
USP
Master’s Degree (partially completed in France – Université Jean Moulin Lyon 3)
2019
USP
PhD
2025
Provided by Chambers
Flávio Augusto Spegiorin Ramos boasts expertise advising clients from the pharmaceutical, food, agricultural, cosmetic, medical device, retail and technology sectors on life sciences-related matters.
Provided by Chambers
A distinguished professional with a strong business mindset. Flávio Spegiorin Ramos has extensive legal expertise and is fully equipped to handle complex client matters.
Flávio has remarkable analytical skills and can navigate complex topics while effectively translating them to meet client needs. We trust his work completely.
A distinguished professional with a strong business mindset. Flávio Spegiorin Ramos has extensive legal expertise and is fully equipped to handle complex client matters.
Flávio has remarkable analytical skills and can navigate complex topics while effectively translating them to meet client needs. We trust his work completely.
9 items provided by Kestener Vieira Torronteguy Spegiorin Advogados
Advertising of Medicines and the Supreme Court
Advertising of Medicines: The Debate Continues at the Supreme Court Amid New Attempts by ANVISA to Reverse the Current Outcome
Advertising of Medicines and Food at the Brazilian Supreme Court
The regulated sector has been talking extensively about the public hearing. However, this is not the only way to participate strategically in the debate—and it may not even be the most effective one.
MAPA Changes Rules for Administrative Proceedings and Procedures for Entering into TACs
In Sep 2025, the Ministry of Agriculture and Livestock published Ordinance No. 1,364/2025 to regulate the execution of Conduct Adjustment Agreements (“TACs”) within the context of agricultural and livestock inspection, in addition to establishing specific procedures for administrative proceedings.
A New Business Landscape Emerges in the Sector Regulated by Anvisa
The arrival of Anvisa’s new Director‑President (economist Leandro Pinheiro Safatle) and the inauguration of the Agency’s new Board of Directors in September 2025 mark the beginning of a significant institutional shift with direct impact on the regulatory and economic environment of the sector.
High‑Exposure Recalls – The New Perception of Reputational Risk and the Shift in Regulatory Approach
Product recall actions involving medicines and food—whether voluntary or mandated by the regulator—have come to be handled with greater rigor by Anvisa, MAPA, and consumer‑protection authorities.
The Cost of Neglecting the Legal Risk Behind a “Simple” Response to ANVISA or MAPA Official Letters
Official letters of this nature actually represent the beginning of a technical‑legal dialogue with significant potential to generate relevant consequences for a company’s operations and/or its rights.
Medicinal Cannabis: New ANVISA Resolutions Redefine the Brazilian Pharmaceutical Market
The new resolutions published in 2026 by the Brazilian Health Regulatory Agency (“Anvisa”) mark a turning point in the regulation of medicinal cannabis in Brazil.
Overview of Access, Litigation, and the Supply of Drugs
Overview of Access, Litigation, and the Supply of Medicines: the Importance of the Industry Analyzing and Monitoring Qualified Data on Judicial Demands
New National System for Phytosanitary Certification of Origin (Sinfito)
New National System for Phytosanitary Certification of Origin (Sinfito): MAPA publishes SDA/MAPA Ordinance No. 1,578/2026 with significant rules on phytosanitary certification and various other provisions applicable to the sector
Advertising of Medicines and the Supreme Court
Advertising of Medicines: The Debate Continues at the Supreme Court Amid New Attempts by ANVISA to Reverse the Current Outcome
Advertising of Medicines and Food at the Brazilian Supreme Court
The regulated sector has been talking extensively about the public hearing. However, this is not the only way to participate strategically in the debate—and it may not even be the most effective one.
MAPA Changes Rules for Administrative Proceedings and Procedures for Entering into TACs
In Sep 2025, the Ministry of Agriculture and Livestock published Ordinance No. 1,364/2025 to regulate the execution of Conduct Adjustment Agreements (“TACs”) within the context of agricultural and livestock inspection, in addition to establishing specific procedures for administrative proceedings.
A New Business Landscape Emerges in the Sector Regulated by Anvisa
The arrival of Anvisa’s new Director‑President (economist Leandro Pinheiro Safatle) and the inauguration of the Agency’s new Board of Directors in September 2025 mark the beginning of a significant institutional shift with direct impact on the regulatory and economic environment of the sector.
High‑Exposure Recalls – The New Perception of Reputational Risk and the Shift in Regulatory Approach
Product recall actions involving medicines and food—whether voluntary or mandated by the regulator—have come to be handled with greater rigor by Anvisa, MAPA, and consumer‑protection authorities.
The Cost of Neglecting the Legal Risk Behind a “Simple” Response to ANVISA or MAPA Official Letters
Official letters of this nature actually represent the beginning of a technical‑legal dialogue with significant potential to generate relevant consequences for a company’s operations and/or its rights.
Medicinal Cannabis: New ANVISA Resolutions Redefine the Brazilian Pharmaceutical Market
The new resolutions published in 2026 by the Brazilian Health Regulatory Agency (“Anvisa”) mark a turning point in the regulation of medicinal cannabis in Brazil.
Overview of Access, Litigation, and the Supply of Drugs
Overview of Access, Litigation, and the Supply of Medicines: the Importance of the Industry Analyzing and Monitoring Qualified Data on Judicial Demands
New National System for Phytosanitary Certification of Origin (Sinfito)
New National System for Phytosanitary Certification of Origin (Sinfito): MAPA publishes SDA/MAPA Ordinance No. 1,578/2026 with significant rules on phytosanitary certification and various other provisions applicable to the sector